The resolution of supply chain problems and the launch of several new products last year helped animal pharmaceutical specialist Animalcare (ANCR) return to sustained organic revenue growth during the half. The new management team has been in place since January and the challenge will be to apply higher value and more complex techniques to reformulating pharmaceuticals for treatment of pets so that the company can maintain its market niches.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis